Resignation of Ms. Bhoomi Patel from the post of Independent director as attached.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Shukra Pharmaceuticals at its meeting on December 30, 2025 accepted the resignation of Ms. Bhoomi Patel (DIN: 08316893) as Independent Director, effective the same day, citing personal reasons. She also stepped down as a member of the Audit, Nomination & Remuneration, and Stakeholders Relationship Committees. Simultaneously, the Board appointed Mr. Dinesh Chauhan (DIN: 11456530) as an Additional Director in the Non-Executive Independent category for a three-year term, subject to shareholder approval. Mr. Chauhan, with over 7 years of experience in business management, has been made Chairperson of all three reconstituted board committees.
This is a routine board reshuffle with an immediate like-for-like replacement, so day-to-day operations and committee oversight should remain uninterrupted. Shareholders will need to approve the new director's appointment at the next AGM; no material governance red flags were flagged in the resignation.